Fellowship · Charlottesville, VA
Sponsored by University of Virginia Medical Center
International Consensus Statement on Obstructive Sleep Apnea.
International forum of allergy & rhinology · 2023 · 291 citations · Mark Quigg
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Neurology · 2024 · 95 citations · Kelly Gwathmey
Diagnosis and management of status epilepticus: improving the status quo.
The Lancet. Neurology · 2025 · 47 citations · Howard Goodkin
Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID.
Neurology(R) neuroimmunology & neuroinflammation · 2022 · 150 citations · Lisa Toran
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Neurology · 2022 · 99 citations · Ted Burns
United States Epilepsy Center Characteristics: A Data Analysis From the National Association of Epilepsy Centers.
Neurology · 2022 · 74 citations · Nathan Fountain
Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia.
Annals of neurology · 2025 · 26 citations · Ifrah Zawar, Mark Quigg, Jaideep Kapur
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.
Nature medicine · 2026 · 14 citations · Kelly Gwathmey